Open original FDA record ↗Recall record
- FDA identifier
- Z-1907-2019
- Company in FDA record
- Phadia Ab
- FDA record creation date
- Jul 1, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Potential for reporting low assay results
Source facts
- Action
- On May 10, 2019, Corporate Thermo Fisher Scientific issued URGENT FIELD SAFETY NOTICES to customers by FedEx. Actions To Be Taken: Please review patient results obtained from lot 0085 and make note of the following: 1. If you have any of the above referenced material on hand, please discontinue use immediately and discard per your internal procedures. Notify all affected users in your facility to do the same. 2. All samples reported as positive (> 5 IU/ml) are positive, however the true concentration could be higher than reported. 3. The true concentration of a reported sample equal to 3.5 5 IU/ml could potentially be a positive sample. 4. Negative results between 2 IU/ml and 3.5 IU/ml are potentially false negative results. 5. Negative results < 2 IU/ml could be higher, but would still be reported as a negative result with a 60% higher concentration. 6. Complete and return the Customer Response Form. If you have any questions concerning this issue, please contact Phadia US, Inc. Technical Support at 1-800-346-4364, option #2.
- Initiated
- 2019-05-10
- Root cause
- Nonconforming Material/Component
- Terminated
- 2020-06-02
- Distribution
- US Nationwide n the states of NJ, NY, MI, WV, TX including PR
- Recall number
- Z-1907-2019
- Recall status
- Terminated
- CDRH record ID
- 173270
- FDA record created
- 2019-07-01
- Recall event number
- 82979